Related Experiment Videos
Burkitt lymphoma in the mouse
A L Kovalchuk1, C F Qi, T A Torrey
1Laboratory of Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
The Journal of Experimental Medicine
|October 18, 2000
Summary
Researchers developed a mouse model for Burkitt lymphoma (BL) by manipulating the MYC gene. This model mimics human BL, offering new insights into B cell lymphoma pathogenesis.
Area of Science:
- Oncology
- Genetics
- Immunology
Background:
- Burkitt lymphoma (BL) is characterized by MYC protooncogene translocations with immunoglobulin genes.
- Deregulated MYC expression is a key driver in BL pathogenesis.
Purpose of the Study:
- To develop a novel mouse model for studying Burkitt lymphoma pathogenesis.
- To investigate the role of MYC dysregulation and regulatory elements in B cell lymphoma development.
Main Methods:
- Engineered mice with a mutated human MYC gene controlled by a reconstructed immunoglobulin lambda locus.
- Observed lymphoma development and characterized tumor phenotypes.
Main Results:
- Mice developed lymphomas with striking similarities to human BL, including a starry sky appearance.
- Monoclonal B cell lymphomas (IgM(+)CD5(-)CD23(-)) arose from polyclonal populations.
- Tumor development was independent of positional effects.
Conclusions:
- MYC dysregulation cooperates with regulatory elements to determine B cell lymphoma phenotype.
- This mouse model provides a new system for investigating BL pathogenesis.